Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

類似資料

• Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
  著者:: Waddington-Cruz, Marcia, 等
  出版事項: (2015)
• Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
  著者:: Leslie Amass, 等
  出版事項: (2018-12-01)
• Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
  著者:: Amass, Leslie, 等
  出版事項: (2018)
• Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
  著者:: Keohane, Denis, 等
  出版事項: (2015)
• Tafamidis delays neurological progression comparably across Val30Met and non‐Val30Met genotypes in transthyretin familial amyloid polyneuropathy
  著者:: Gundapaneni, B. K., 等
  出版事項: (2017)